The Difference between COVID-19, the Flu, Allergies, RSV, and a Cold

By jsmith | January 13, 2022

We’ve all been there; you wake up with a sore throat and your brain immediately starts rattling off the possible sicknesses you’ve caught. With cold and flu season colliding with COVID-19 spikes, it’s hard to tell what you’ve come down with. Cue the frantic Googling! To help settle some of the confusion, we’ve provided a…

Read More

10 Fresh Approaches to the New Year

By jsmith | December 27, 2021

In a few days, we’ll be watching the ball drop and welcoming 2022! For some, a new year brings a chance to have a fresh start, but for others, the pressure of “starting over” every January can feel overwhelming. We’re discussing a few healthy intentions you can take with you into the new year and…

Read More

A $13 million micro-hospital planned for Milwaukee’s far south side has won a key city approval. It would serve 10 to 40 patients a day.

By NutexMarketing | December 9, 2021

Written by Tom Daykin Dec 8, 2021, 2:27 p.m. CT NEWS PROVIDED BY: Milwaukee Journal Sentinel A micro-hospital planned for Milwaukee’s far south side has won a key city approval. Houston-based Nutex Health Inc. wants to develop a 22,073-square-foot hospital at 1801-1909 W. Layton Ave., just west of I-94. The hospital would have six to eight inpatient beds…

Read More

Clinigence Holdings And Nutex Health Announce Transformational Merger

By NutexMarketing | November 29, 2021

Published on Cision PR Newswire Nov 24, 2021, 16:05 ET NEWS PROVIDED BY: Clinigence Holdings FT. LAUDERDALE, Fla. and HOUSTON, Nov. 24, 2021 /PRNewswire/ — Clinigence Holdings, Inc. (“Clinigence” or the “Company”) (OTC:CLNH), a leading technology-enabled, risk-bearing population health management company, and Nutex Health, LLC (together with its affiliates, “Nutex”), one of the largest independent operators of micro-hospitals and…

Read More

Diabetes: Risks and Warning Signs

By jsmith | November 12, 2021

November is American Diabetes Month (ADM), a time to raise awareness and talk about preventing and managing diabetes. More than 30 million Americans have diabetes, and an additional 84 million people in the U.S. are at high risk of developing type 2 diabetes. This month, we’re reviewing how to maintain a healthy lifestyle while living…

Read More

The Best and Worst Candy for Kid’s Teeth

By NutexMarketing | October 28, 2021

During October, grocery store aisles are lined with candy corn, festive cookies, frosted cupcakes, and every type of candy under the sun. Thanks to all the gooey goodness, it’s only appropriate that October is National Dental Hygiene Month! Types of Candy Let’s talk Halloween candy—what’s okay, and what you may want to skip on buying…

Read More

Women’s Ovarian Health

By jsmith | September 27, 2021

Do you know what’s going on in your ovaries? September is Ovarian Cancer Awareness Month and Polycystic Ovarian Syndrome Awareness Month. We’re covering both issues on the blog today because women’s reproductive health deserves to be talked about more. Let’s dive in!   Ovarian Cancer Although it’s called ovarian cancer, it can develop outside of…

Read More

What You Need to Know About CPR

By jsmith | July 28, 2021

Countless lives are saved every day by cardiopulmonary resuscitation, or CPR, and it’s some of the most valuable knowledge you can have. This week on the blog, we’re covering the basics of CPR, including when and how to give it. When to use CPR If someone is not breathing, it’s time to perform CPR. CPR…

Read More

Nutex Health Celebrates 10 Year Anniversary

By jsmith | June 24, 2021

Contact: Vivian Urrea Company: Nutex Health Tel: 713-660-0557 Email: For Immediate Release HOUSTON—June 24, 2021—Nutex Health celebrates a remarkable 10 years of business with a company event at their headquarters in Texas. Founded in 2011 by CEO Dr. Tom Vo, Nutex Health is a premier service provider, operator and management firm in the healthcare…

Read More

FDA Approves Breakthrough Drug for Alzheimer’s Disease

By jsmith | June 8, 2021

The FDA has granted accelerated approval for Aduhelm (aducanumab), a drug used to treat Alzheimer’s disease. Drugs approved under the accelerated approval pathway have proven to be more beneficial than what’s currently on the market for life-threatening illnesses. Considering Aduhelm is the first drug of its kind and the first Alzheimer’s treatment to be approved…

Read More